← All QL Wire
Share:
$GILD QuantLogix Newsdesk · 11/20/2026, 6:03 PM UTC

Mizuho Lifts Gilead Sciences Price Target to $182 From $170

What happened

Mizuho Securities raised its price target on Gilead Sciences to $182 from $170 on November 20, 2026. The firm maintained its Outperform rating on the stock. The revision follows the analyst's updated view on the company's outlook. Gilead shares traded at $168.48, up 1.06% on the session. No changes to earnings estimates were disclosed in the note.

The QL Read

Gilead's QuantLogix composite sits at 65/100 (Neutral), and the stock's +1.06% day against a risk-off tape (VIX 32.37, 26.8% of names advancing) stands out — XLV gained 0.54% while tech fell 5.38%. The raised $182 target arrives with the engine's read already constructive.

Source: Fiscal.ai — "Mizuho Securities Adjusts Gilead Sciences Price Target to $182 From $170" — 2026-11-20T16:02:12Z
Not financial advice. QuantLogix is a research platform; nothing in this brief constitutes a recommendation to buy or sell any security. We summarize public news with attribution to the original publisher; visit the source above for the full original article.